Diamidex
1 known investors
Diamidex develops rapid microbial detection and enumeration methods for laboratories, covering pathogens such as Legionella pneumophila, E. coli, coliforms, and Pseudomonas aeruginosa. Its solutions deliver results in colony forming units up to five times faster than standard methods while reducing labor time.
BiotechDeep TechMedical Devices